Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 14;11(11):CD005598.
doi: 10.1002/14651858.CD005598.pub4.

Antibiotics for treating community-acquired pneumonia in people with sickle cell disease

Arturo J Martí-Carvajal  1 , Lucieni O Conterno
Affiliations

Antibiotics for treating community-acquired pneumonia in people with sickle cell disease

Arturo J Martí-Carvajal et al. Cochrane Database Syst Rev. .

Abstract

Background: As a consequence of their condition, people with sickle cell disease are at high risk of developing an acute infection of the pulmonary parenchyma called community-acquired pneumonia. Many different bacteria can cause this infection and antibiotic treatment is generally needed to resolve it. There is no standardized approach to antibiotic therapy and treatment is likely to vary from country to country. Thus, there is a need to identify the efficacy and safety of different antibiotic treatment approaches for people with sickle cell disease suffering from community-acquired pneumonia. This is an update of a previously published Cochrane Review.

Objectives: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.

Search methods: We searched The Group's Haemoglobinopathies Trials Register (01 September 2016), which comprises references identified from comprehensive electronic database searches and handsearching of relevant journals and abstract books of conference proceedings. We also searched LILACS (1982 to 01 September 2016), African Index Medicus (1982 to 20 October 2016) and WHO ICT Registry (20 October 2016).

Selection criteria: We searched for published or unpublished randomized controlled trials.

Data collection and analysis: We intended to summarise data by standard Cochrane methodologies, but no eligible randomized controlled trials were identified.

Main results: We were unable to find any randomized controlled trials on antibiotic treatment approaches for community-acquired pneumonia in people with sickle cell disease.

Authors' conclusions: The updated review was unable to identify randomized controlled trials on efficacy and safety of the antibiotic treatment approaches for people with sickle cell disease suffering from community-acquired pneumonia. Randomized controlled trials are needed to establish the optimum antibiotic treatment for this condition. The trials regarding this issue should be structured and reported according to the CONSORT statement for improving the quality of reporting of efficacy and improved reports of harms in clinical research. Triallists should consider including the following outcomes in new trials: number of days to become afebrile; mortality; onset of pain crisis or complications of sickle cell disease following community-acquired pneumonia; diagnosis; hospitalization (admission rate and length of hospital stay); respiratory failure rate; and number of participants receiving a blood transfusion.There are no trials included in the review and we have not identified any relevant trials up to September 2016. We therefore do not plan to update this review until new trials are published.

PubMed Disclaimer

Conflict of interest statement

All authors: none known.

Update of

Similar articles

See all similar articles

Cited by

References

Additional references

Adamkiewicz 2003
    1. Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. Journal of Pediatrics 2003;143(4):438-44. - PubMed
Arason 1996
    1. Arason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996;313(7054):387-91. - PMC - PubMed
ASH 2008
    1. Kaushansky K. Special Needs Plan for Chronic Conditions. http://www.hematology.org/policy/testimony/ASH_Comments_re_Special_Needs... (accessed November 1st 2008).
Ashley‐Koch 2000
    1. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. American Journal of Epidemiology 2000;151(9):839-45. - PubMed
Ballas 2010
    1. Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C et al. Definitions of the phenotypic manifestations of sickle cell disease. American Journal of Hematology 2010;85(1):6-13. - PMC - PubMed
Balshem 2011
    1. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. [PMID: ] - PubMed
Bartlett 2000
    1. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clinical Infectious Disease 2000;31(2):347-82. - PMC - PubMed
Battersby 2010
    1. Battersby AJ, Knox-Macaulay HH, Carrol ED. Susceptibility to invasive bacterial infections in children with sickle cell disease. Pediatric Blood & Cancer 2010;55(3):401-6. - PubMed
Begue 2001
    1. Begue P, Castello-Herbreteau B. Severe infections in children with sickle cell disease: clinical aspects and prevention [Infections graves chez renfant l´ drèpanocytaire aspects cliniques et prèvention]. Archives de Pediatrie 2001;8(Suppl 4):732s-41s. - PubMed
Beytout 2003
    1. Beytout J, Tournilhac O, Laurichesse H. Asplenia and hyposplenism. La Presse Medicale 2003;32(28 Suppl):S5-9. - PubMed
Bogaert 2004
    1. Bogaert D, Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infectious Disease 2004;4(3):144-54. - PubMed
Bonds 2005
    1. Bonds DR. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Review 2005;19(2):99-110. - PubMed
Castagnola 2003
    1. Castagnola E, Fioredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. European Journal of Haematology 2003;71(5):319-26. - PubMed
Castro 1994
    1. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84(2):643-9. - PubMed
Castro 2005
    1. Castro O, Gladwin MT. Pulmonary Hypertension in Sickle Cell Disease: Mechanisms, Diagnosis, and Management. Hematology/Oncology Clinics of North America 2005;19(5):881-96. - PubMed
Chalmers 2004
    1. Chalmers I. Well informed uncertainties about the effects of treatments. BMJ 2004;328(7438):475-6. - PMC - PubMed
Chanet 2004
    1. Chanet V, Lesens O, Laurichesse H, Beytout J. Prevention and infection in adults patients with hyposplenism [Infections chez l'adulte asplénique et prévention]. Medecine et maladies infectieuses 2004;34(11):493-8. - PubMed
Davies 2004
    1. Davies EG, Hirst C, Lottenberg R, Dower N. Pneumococcal vaccines for sickle cell disease. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No: CD003885. [DOI: 10.1002/14651858.CD003885.pub2] - DOI - PMC - PubMed
De Ceulaer 1985
    1. De Ceulaer K, McMullen KW, Maude GH, Keatinge R, Serjeant GR. Pneumonia in young children with homozygous sickle cell disease: risk and clinical features. European Journal of Pediatrics 1985;144(3):255-8. - PubMed
Dean 2003
    1. Dean D, Neumayr L, Kelly DM, Ballas SK, Kleman K, Robertson S, et al. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. Journal of Pediatric Hematology/Oncology 2003;25(1):46-55. - PubMed
Di Sabatino 2005
    1. Di Sabatino A, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Corazza GR et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. The American Journal of Gastroenterology 2005;100(8):1788-95. - PubMed
Falcao 1989
    1. Falcao RP, Donadi EA. Infection and immunity in sickle cell disease. Revista da Associacao Medica Brasileira 1989;35(2):70-4. - PubMed
File 2004
    1. File TM. Streptococcus pneumoniae and community-acquired pneumonia: A cause for concern. American Journal of Medicine 2004;117(Suppl 3A):39S–50S. - PMC - PubMed
Fleming 1989
    1. Fleming AF. The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Review 1989;3(1):18-28. - PubMed
Gaston 1986
    1. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G et al. Prophylaxis with oral penicillin in children with sickle cell anemia. New England Journal of Medicine 1986;314(25):1593-9. - PubMed
Gilbert 2008
    1. Gilbert DN. Clinical end points of therapy for patients with mild community-acquired pneumonia. Clinical Infectious Diseases 2008;47(Suppl 3):140-4. - PubMed
Golden 1998
    1. Golden C, Styles L, Vichinsky E. Acute chest syndrome and sickle cell disease. Current Opinion in Hematology 1998;5(2):89-92. - PubMed
GRADEPro 2014 [Computer program]
    1. GRADE Working Group, McMaster University GRADEpro GDT. Version accessed 09 November 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
Guyatt 2011a
    1. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93. [PMID: ] - PubMed
Guyatt 2011b
    1. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294-302. [PMID: ] - PubMed
Guyatt 2011c
    1. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence--publication bias. Journal of Clinical Epidemiology 2011;64(12):1277-82. [PMID: ] - PubMed
Guyatt 2011d
    1. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. Journal of Clinical Epidemiology 2011;64(12):1303-10. [PMID: ] - PubMed
Guyatt 2011e
    1. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311-6. [PMID: ] - PubMed
Guyatt 2011f
    1. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407-15. [PMID: ] - PubMed
Guyatt 2011g
    1. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94. [PMID: ] - PubMed
Guyatt 2011h
    1. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology 2011;64(4):380-2. [PMID: ] - PubMed
Haas 2005
    1. Haas H. Antibiotherapy in children with atypical bacterial infections [Antibiothérapie des infections à bactéries atypiques de l'enfant]. Archives de pediatrie 2005;12(Suppl 1):S45-8. - PubMed
Hampton 2005
    1. Hampton R, Balasa V, Allen Bracey SE. Emergencies in patients with inherited hemoglobin disorders—An emergency department perspective. Clinical Pediatric Emergency Medicine 2005;6(3):138-48.
Hebbel 2004
    1. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004;11:129-51. - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
ICH‐GCP 1997
    1. International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice. www.ich.org/cache/compo/276-254-1.html (accessed 18th May 2006).
ISDA 2008
    1. Infectious Diseases Society of America. Position Paper: Recommended Design Featuresof Future Clinical Trials of Antibacterial Agents for Community-Acquired Pneumonia. Clinical Infectious Diseases 2008;47(Suppl 3):249-65. - PMC - PubMed
Jacobs 2004
    1. Jacobs MR. Streptococcus pneumoniae: epidemiology and patterns of resistance. American Journal of Medicine 2004;117(Suppl 3A):3S-15S. - PubMed
Jain 2002
    1. Jain S, Sullivan K. Ceftriaxone use in the emergency department: are we doing it right? Pediatric Emergency Care 2002;18:259-64. - PubMed
Kakaiya 2004
    1. Kakaiya R, Cseri J, Smith S, Silberman S, Rubinas TC, Hoffstadter A. A case of acute hemolysis after ceftriaxone: immune complex mechanism demonstrated by flow cytometry. Archives of Pathology and Laboratory Medicine 2004;128:905-7. - PubMed
Klugman 2004
    1. Klugman KP, Low DE, Metlay J, Pechere JC, Weiss K. Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities. International Journal of Antimicrobial Agents 2004;24(5):411-22. - PubMed
Knight 1999
    1. Knight J, Murphy TM, Browning I. The lung in sickle cell disease. Pediatric Pulmonology 1999;28(3):205-16. - PubMed
Landesman 1982
    1. Landesman SH, Rao SP, Ahonkhai VI. Infections in children with sickle cell anemia. Special reference to pneumococcal and salmonella infections. The American Journal of Pediatric Hematology/Oncology 1982;4(4):407-18. - PubMed
Lane 1995
    1. Lane PA, O'Connell JL, Lear JL, Rogers ZR, Woods GM, Hassell KL et al. Functional asplenia in hemoglobin SC disease. Blood 1995;85(8):2238-44. - PubMed
Lepage 2004
    1. Lepage P, Dresse MF, Forget P, Schmitz V, Hoyoux C. Infections and antibiotic prophylaxis in sickle cell disease. Revue Medicale de Liege 2004;59(3):145-48. - PubMed
Lottenberg 2005
    1. Lottenberg R, Hassell KL. An evidence-based approach to the treatment of adults with sickle cell disease. In: Hematology (Am Soc Hematol Educ Program). The American Society of Hematology, 2005. - PubMed
Loureiro 2005
    1. Loureiro MM, Rozenfeld S. Epidemiology of sickle cell disease hospital admissions in Brazil. Revista de Saúde Pública 2005;39(6):943-9. - PubMed
Machado 2005
    1. Machado RF, Gladwin MT. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. British Journal of Hematology 2005;129(4):449-64. - PubMed
Maitre 2011
    1. Mâitre B, Mekontso-Dessap A, Habibi A, Bachir D, Parent F, Godeau B et al. Pulmonary complications in adult sickle cell disease [Complications pulmonaires des syndromes drepanocytaires majeurs chez l'adulte.]. Revue des Maladies Respiratoires 2011;28(2):129-37. - PubMed
Makani 2007
    1. Makani J, Williams TN, Marsh K. Sickle cell disease in Africa: burden and research priorities. Annals of tropical medicine and parasitology 2007;101(1):3-14. [PMID: ] - PMC - PubMed
Makani 2011
    1. Makani J, Cox SE, Soka D, Komba AN, Oruo J, Mwamtemi H et al. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PloS one 2011;6(2):e14699. - PMC - PubMed
Melles 2004
    1. Melles DC, Marie S. Prevention of infections in hyposplenic and asplenic patients: an update. The Netherlands Journal of Medicine 2004;62(2):45-52. - PubMed
Metlay 2004
    1. Metlay JP. Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia. Infectious disease clinics of North America 2004;18(4):777-90. - PubMed
Miller 2007
    1. Miller ML, Gao G, Pestina T, Persons D, Tuomanen E. Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor. Journal of Infectious Disease 2007;195:581-4. [MEDLINE: ] - PubMed
Modell 2008
    1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization 2008;86(6):480-7. - PMC - PubMed
Mortensen 2002
    1. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Archives of Internal Medicine 2002;162(9):1059-64. - PubMed
Mousa 2010
    1. Mousa SA, Qari MH. Diagnosis and management of sickle cell disorders. Methods in Molecular Biology 2010;663:291-307. - PubMed
Neumayr 2003
    1. Neumayr L, Lennette E, Kelly D, Earles A, Embury S, Groncy P, et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics 2003;112(1 Pt 1):87-95. - PubMed
NIH 2002
    1. National Heart, Lung, and Blood Institute, Division of Blood Disease and Resources. The Management of Sickle Cell Disease. 4th edition. National Institutes of Health, 2002.
Orkin 2010
    1. Orkin SH, Higgs DR. Medicine. Sickle cell disease at 100 years. Science 2010;329(5989):291-2. - PubMed
Overturf 1999
    1. Overturf GD. Infections and immunizations of children with sickle cell disease. Advances in Pediatric Infectious Diseases 1999;14:191-218. - PubMed
Overturf 2000
    1. Overturf GD. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000;106(2 Pt 1):367-76. - PubMed
Paradisi 2000
    1. Paradisi F, Corti G. Antibiotic resistance in community-acquired pulmonary pathogens. Seminars in Respiratory and Critical Care Medicine 2000;21(1):33-43. - PubMed
Pauling 1949
    1. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science 1949;110(2865):543-6. - PubMed
Pelton 2005
    1. Pelton SI, Hammerschlag MR. Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children. Clinical Pediatrics 2005;44(1):1-17. - PubMed
Petri 2001
    1. Petri Jr WA. Penicillins, cephalosporins, and other β-lactam antibiotics. In: Hardman JG, Limbird LE, editors(s). Goodman & Gilman's. The Pharmacological Basis of Therapeutics. 10 edition. New York: McGraw Hill, 2001:1189-218.
Pimentel 2003
    1. Pimentel L, McPherson SJ. Community-acquired pneumonia in the emergency department: a practical approach to diagnosis and management. Emergency Medicine Clinics of North America 2003;21(2):395-420. - PubMed
Plouffe 2004
    1. Plouffe Jr JF, Martin DR. Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae. Infectious Disease Clinics of North America 2004;18(4):963–74. - PMC - PubMed
Prabhakar 2010
    1. Prabhakar H, Haywood C Jr, Molokie R. Sickle cell disease in the United States: looking back and forward at 100 years of progress in management and survival. American Journal of Hematology 2010;85(5):346-53. - PubMed
Ramakrishnan 2010
    1. Ramakrishnan M, Moisi JC, Klugman KP, Iglesias JM, Grant LR, Mpoudi-Etame M et al. Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. The Lancet Infectious Diseases 2010;10(5):329-37. - PubMed
Rees 2010
    1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010;376(9757):2018-31. - PubMed
RevMan 2011 [Computer program]
    1. The Cochrane Collaboration Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2011.
Sandora 2005
    1. Sandora TJ, Harper MB. Pneumonia in hospitalized children. Pediatric Clinics of North America 2005;52(4):1059-81. - PMC - PubMed
Saunthararajah 2005
    1. Saunthararajah Y, Vichinsky EP, Embury SH. Sickle cell disease. In: Hematology: Basic Principles and Practice. Churchill Livingstone, 2005.
Segreti 2005
    1. Segreti J, House HR, Siegel RE. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. American Journal of Medicine 2005;118(Suppl 7A):21S-8S. - PubMed
Selim 2010
    1. Selim AG, Balalis G, Bhaskar B, Driel ML. Antibiotics for ventilator-associated pneumonia. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No: CD004267. [DOI: 10.1002/14651858.CD004267.pub3] - DOI - PMC - PubMed
Serjeant 2010
    1. Serjeant GR. One hundred years of sickle cell disease. British Journal of Haematology 2010;151(5):425-9. - PubMed
Siddiqui 2003
    1. Siddiqui AK, Ahmed S. Pulmonary manifestations of sickle cell disease. Postgraduate Medical Journal 2003;79(933):384-90. - PMC - PubMed
Steinberg 2009
    1. Steinberg MH. Genetic etiologies for phenotypic diversity in sickle cell anemia. TheScientificWorldJournal 2009;9:46-67. [PMID: ] - PMC - PubMed
Stuart 2001
    1. Stuart MJ, Setty BN. Acute chest syndrome of sickle cell disease: new light on an old problem. Current Opinion Hematology 2001;8(2):111-22. - PubMed
Stuart 2004
    1. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364(9442):1343-60. - PubMed
Tan 2004
    1. Tan JS. Nonresponses and treatment failures with conventional empiric regimens in patients with community-acquired pneumonia. Infectious Disease Clinics of North America 2004;18(4):883-97. - PubMed
Vichinsky 1997
    1. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997;89(5):1787-92. - PubMed
Vichinsky 2000
    1. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine 2000;342(25):1855-65. - PubMed
Vij 2010
    1. Vij R, Machado RF. Pulmonary complications of hemoglobinopathies. Chest 2010;138(4):973-83. - PubMed
Waghorn 2001
    1. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. Journal Clinical of Patholology 2001;54(3):214-8. - PMC - PubMed
Waterer 2005
    1. Waterer GW, Wunderink RG. Genetic susceptibility to pneumonia. Clinics in chest medicine 2005;26(1):29-38. - PubMed
Weatherall 2006
    1. Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P. Inherited Disorders of Hemoglobin. In: Disease Control Priorities in Developing Countries. Vol. 2nd edition. Washington DC: The World Bank and Oxford University Press, 2006.
WHO 2002
    1. World Health Organization. Evidence base for the community management of pneumonia. http://www.who.int/child-adolescent-health/New_Publications/CHILD_HEALTH... (accessed 29 December 2005).
WHO 2004
    1. WHO 2004. Pneumococcal vaccines. http://www.who.int/vaccines/en/pneumococcus.shtml (accessed 04 February 2005).
WHO 2005
    1. World Health Organization. Monogenic diseases. http://www.who.int/genomics/public/geneticdiseases/en/index2.html#SCA (accessed 29 December 2005).
Wood 2008
    1. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radical Biology and Medicine 2008;44(8):1506-28. - PubMed
Zago 1983
    1. Zago MA, Bottura C. Splenic function in sickle-cell diseases. Clinical Science (London, England : 1979) 1983;65(3):297-302. - PubMed

References to other published versions of this review

Martí‐Carvajal 2006
    1. Martí-Carvajal AJ, Conterno L. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No: CD005598. [DOI: 10.1002/14651858.CD005598.pub2] - DOI - PubMed
Martí‐Carvajal 2012
    1. Martí-Carvajal AJ, Conterno LO. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No: CD005598. [DOI: 10.1002/14651858.CD005598.pub3] - DOI - PubMed

Publication types

MeSH terms

Substances